跳至主要内容
临床试验/IRCT20201007048956N1
IRCT20201007048956N1已完成3 期

Eradication Efficacy of high dose amoxicillin and PPI Compared with standard bismuth containing quadruple Therapy as a First Line Treatment of Helicobacter pylori

Ahvaz University of Medical Sciences0 个研究点目标入组 220 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • chronic gastritis with or without healed duodenal or stomach ulcer
  • H. pylori positive determined by Rapid UreaseTest or Urea Breath Test
  • treatment-naive patients for eradication of H. pylori infection

排除标准

  • allergy to medications used in this clinical trial
  • use of PPI, histamine H2-receptor antagonists, antibiotics, bismuth, or probiotics 4 weeks before initiating study
  • pregnancy or breastfeeding

研究者

相似试验